Skandinaviska Enskilda Banken AB publ grew its holdings in shares of Cabot Co. (NYSE:CBT - Free Report) by 17.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 47,300 shares of the specialty chemicals company's stock after purchasing an additional 7,000 shares during the period. Skandinaviska Enskilda Banken AB publ owned 0.09% of Cabot worth $4,287,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of CBT. R Squared Ltd acquired a new stake in shares of Cabot in the 4th quarter worth about $26,000. First Horizon Advisors Inc. increased its holdings in shares of Cabot by 22.0% in the 3rd quarter. First Horizon Advisors Inc. now owns 650 shares of the specialty chemicals company's stock worth $73,000 after acquiring an additional 117 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Cabot by 37.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock worth $74,000 after acquiring an additional 219 shares during the period. GAMMA Investing LLC increased its holdings in shares of Cabot by 10.7% in the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock worth $123,000 after acquiring an additional 130 shares during the period. Finally, Manchester Capital Management LLC increased its holdings in shares of Cabot by 1,685.1% in the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock worth $153,000 after acquiring an additional 1,584 shares during the period. Institutional investors and hedge funds own 93.18% of the company's stock.
Cabot Price Performance
Cabot stock traded down $1.67 during trading hours on Thursday, hitting $82.49. 285,468 shares of the company traded hands, compared to its average volume of 347,159. The firm has a market cap of $4.47 billion, a P/E ratio of 10.95, a P/E/G ratio of 0.74 and a beta of 1.21. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72. The firm's 50-day simple moving average is $86.57 and its two-hundred day simple moving average is $99.04. Cabot Co. has a 1-year low of $79.57 and a 1-year high of $117.46.
Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, analysts forecast that Cabot Co. will post 7.57 earnings per share for the current fiscal year.
Cabot Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date of this dividend was Friday, February 28th. Cabot's dividend payout ratio (DPR) is presently 22.84%.
Cabot announced that its board has initiated a share buyback plan on Tuesday, December 3rd that allows the company to repurchase 10,000,000 shares. This repurchase authorization allows the specialty chemicals company to purchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its shares are undervalued.
Wall Street Analysts Forecast Growth
CBT has been the topic of a number of analyst reports. JPMorgan Chase & Co. dropped their price objective on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a report on Friday, February 21st. Mizuho lowered their target price on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 7th. Finally, StockNews.com cut shares of Cabot from a "buy" rating to a "hold" rating in a research note on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $97.00.
Check Out Our Latest Analysis on Cabot
Cabot Company Profile
(
Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Articles

Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.